Cengild Medical BhdXKLS:0243 67 EV-to-FCF is -3.17 as of Jul. 02, 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 67/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Cengild Medical Bhd ranks worse than 246305.17% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cengild Medical Bhd's Enterprise Value is RM197.73 Mil.
Cengild Medical Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was RM-62.46 Mil. Therefore, Cengild Medical Bhd's EV-to-FCF for today is -3.17.
The historical rank and industry rank for Cengild Medical Bhd's EV-to-FCF or its related term are showing as below:
XKLS:0243'
s EV-to-FCF Range Over the Past 10 Years
Min: -235.83 Med: -3.23 Max: 42.28
Current: -3.17
During the past 8 years, the highest EV-to-FCF of Cengild Medical Bhd was 42.28. The lowest was -235.83. And the median was -3.23.
XKLS:0243's EV-to-FCF is ranked worse than 100% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.57
vs XKLS:0243: -3.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cengild Medical Bhd (XKLS:0243) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cengild Medical Bhd's PE Ratio (TTM) for today is calculated as:
Cengild Medical Bhd's share price for today is RM0.20.
Cengild Medical Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cengild Medical Bhd EV-to-FCF Related Terms
Cengild Medical Bhd EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cengild Medical Bhd's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's EV-to-FCF falls into.
Cengild Medical Bhd's current Enterprise Value is RM197.73 Mil.
Cengild Medical Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-62.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd (XKLS:0243) has a EV-to-FCF of -3.17 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cengild Medical Bhd and its competitors. According to the industry distribution chart, Cengild Medical Bhd ranks #999999 out of 406 companies in the Healthcare Providers & Services industry.
Is Cengild Medical Bhd's EV-to-FCF too high?
Cengild Medical Bhd's current EV-to-FCF is -3.17. Based on the distribution chart, Cengild Medical Bhd ranks #999999 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cengild Medical Bhd has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #999999 out of 406 companies for EV-to-FCF. This places Cengild Medical Bhd in the lower half of its industry. The industry median EV-to-FCF is 17.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.57, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current EV-to-FCF is -3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 31% below its estimated fair value. The current EV-to-FCF is -3.17. Cengild Medical Bhd's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current EV-to-FCF is -3.17 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 31% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
EV-to-FCF: -3.17
GF Value™: RM0.29 vs. price of RM0.20 (31% below fair value)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
67GF Score
Get the complete analysis for XKLS:0243
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
